Abata Therapeutics Appoints Joanne Beck, Ph.D., as Chief Technical Officer
September 16, 2024 07:00 ET
|
Abata
Abata Therapeutics Appoints Joanne Beck, Ph.D., as Chief Technical Officer
Abata Therapeutics Receives FDA Fast Track Designation for ABA-101 for the Treatment of Progressive Multiple Sclerosis
August 22, 2024 07:00 ET
|
Abata
Abata Therapeutics Receives FDA Fast Track Designation for ABA-101 for the Treatment of Progressive Multiple Sclerosis
Abata Therapeutics Announces Strategic Investment from Bristol Myers Squibb Supporting Advancement of its Treg Cell Therapy Pipeline into Clinical Development
August 15, 2024 07:00 ET
|
Abata
Abata Therapeutics Announces Strategic Investment from Bristol Myers Squibb Supporting Advancement of its Treg Cell Therapy Pipeline
Humacyte Second Quarter 2024 Financial Results and Business Update
August 13, 2024 07:00 ET
|
Humacyte, Inc
-FDA requires additional time to complete its review of ATEV™ (acellular tissue engineered vessel) BLA for the Treatment of Vascular Trauma- -Reported Positive Topline Results from Phase 3 Trial of...
Abata Therapeutics Announces FDA Clearance of Investigational New Drug Application for Clinical Evaluation of ABA-101 in Progressive Multiple Sclerosis
July 09, 2024 06:00 ET
|
Abata
Abata Therapeutics Announces FDA Clearance of Investigational New Drug Application for Clinical Evaluation of ABA-101 in Progressive Multiple Sclerosis
Humacyte Presents Positive Preclinical Data For Its BioVascular Pancreas (BVP™) Program
June 25, 2024 08:00 ET
|
Humacyte, Inc
– BioVascular Pancreas (BVP) product candidate is under development as a potential treatment for type 1 diabetes – – Humacyte’s stem cell-derived islets observed to restore normal blood glucose...
JDRF Walk to Cure Diabetes
May 31, 2024 10:00 ET
|
Juvenile Diabetes Research Foundation
TORONTO, May 31, 2024 (GLOBE NEWSWIRE) -- The JDRF Walk to Cure Diabetes is the largest fundraising event in Canada that brings together the type 1 diabetes (T1D) community to raise funds for T1D...
vTv Therapeutics Announces 2024 First Quarter Financial Results and Provides Corporate Update
May 09, 2024 16:51 ET
|
vTv Therapeutics Inc.
HIGH POINT, N.C., May 09, 2024 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical stage biopharmaceutical company focused on the development of an adjunctive therapy to insulin for...
Eledon Announces Clinical Progress with Tegoprubart in the Prevention of Transplant Rejection
May 07, 2024 07:05 ET
|
Eledon Pharmaceuticals, Inc.
Eledon Announces Clinical Progress with Tegoprubart in the Prevention of Transplant Rejection
Evox Therapeutics Names Co-Founder Dr. Per Lundin as Chief Executive Officer
April 29, 2024 02:00 ET
|
EVOX THERAPEUTICS LIMITED
Evox Therapeutics announces the appointment of Dr. Per Lundin as Chief Executive Officer